|
Validation of ECG Waveform and Arrhythmia Diagnosis Concordance for Pediatric Patients Using ECG Monitoring Patch
RECRUITINGN/ASponsored by Mezoo Co., Ltd.
Actively Recruiting
PhaseN/A
SponsorMezoo Co., Ltd.
Started2023-01-16
Est. completion2024-12-30
Eligibility
Age29 Days – 19 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05756309
Summary
This study will verify the 1-channel patch-type ECG's arrhythmia diagnostic concordance rate and electrocardiogram measurement performance in pediatric patients by collecting ECG signals from patch-type ECG and Holter device simultaneously for data analysis.
Eligibility
Age: 29 Days – 19 YearsHealthy volunteers accepted
Inclusion Criteria: * More than 29 days old and less than 19 years old * Patients who are need regular Holter electrocardiography among outpatients or hospitalized patients at the Pediatrics, Samsung Medical Center * Those who gave written consent to this clinical study or obtained the written consent of the legal representative Exclusion Criteria: * Patients who cannot give consent through the patient ownself or legal representative * If the researcher judges that participation in this study is inappropriate for other reasons
Conditions2
Arrhythmias, CardiacHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMezoo Co., Ltd.
Started2023-01-16
Est. completion2024-12-30
Eligibility
Age29 Days – 19 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05756309